PUTNAM, CT USA – (March 23, 2018) – Foster Corporation, a leader in polymer solutions for healthcare markets, has been appointed distributor of Repsol’s healthcare polyolefins portfolio: polypropylene, polyethylene and ethylene-vinyl acetate (EVA) copolymers for the North American healthcare markets effective January 1, 2018.  Repsol Healthcare^® medical grade polyolefins are used in a wide range of healthcare applications from syringe barrels to medical bags.

Repsol offers 27 grades of polyolefins specifically for healthcare applications. These include polypropylene homopolymers and copolymers, low density and high density polyethylene (i.e.: LDPE, HDPE), and EVA copolymers with vinyl acetate content ranging from 7.5% to 28%.  These medical-grade polymers meet USP Class VI and ISO 10993 requirements.

“Polyolefins are used in more medical devices and packaging than any other thermoplastic.  Today, these economical polymers are being evaluated for a wider range of applications than ever before,” said Larry Johnson, Executive Vice President of Foster Corporation. “To support medical device development from prototype through production, we offer Repsol polypropylene, polyethylene and EVA copolymer medical grades in 25 kg (55 lb) through truckload quantities.”

For more information about available medical-grade Repsol Healthcare polyolefins, please visit www.fosterpolymers.com or www.repsol.com.